1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. VIRIDIAN THERAPEUTICS INC
Viridian Therapeutics Inc XNAS: VRDN

Viridian Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Momentum Trap
about

Viridian Therapeutics Inc is a clinical-stage biopharmaceutical company that engages in developing multiple product candidates to treat patients who suffer from thyroid eye disease. Its product candidate includes Veligrotug (formerly known as VRDN-00...

Read More
31.99 -0.58 (-1.78%)
223.13% Gain from 52W Low
1.3M
XNAS Volume

XNAS 13 Jan, 2026 4:30 PM (EST)

Watchlist

Portfolio

Alert
Durability score
Low Financial Strength
22.2 / 100
Valuation Score
Expensive Valuation
6.3 / 100
Momentum Score
Technically Moderately Bullish
69.9 / 100
Momentum Trap These stocks have weak financials and expensive valuation. Buying interest may quickly dissipate. Investors should exercise caution View Similar Embed DVM
Analyst Price Target
42
1Yr Price target upside is 30%
17 analysts

16

S

8

W

6

O

0

T

SWOT Analysis

Viridian Therapeutics Inc Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..